Home
  • About Diabetic
    Foot Causes
    • Diabetic Foot Causes
    • Diabetic Foot Symptoms
    • Diabetic Foot Complications
    • Diabetic Foot Treatment
    • Preventing Diabetic Foot
    • Educational Handbook
  • Selecting
    Fespixion
    • Development Process
    • Clinical Trials
    • Mechanism
    • Literature Review
    • Quality Certification
  • Starting
    Fespixion
    • Indications and Dosagen
    • Drug Safety
    • Package Insert
    • Usage Videos
  • Stories
    • Popular Articles
    • Popular Videos
  • About
    Oneness
    • Company Introduction
    • Core Values and Business Philosophy
    • Corporate Sustainable Responsibility
  • Contact Us
  • 繁
  • 简
  • EN

Literature Review

2022-06-01
JID Innovations
Publication
Restoring Pro-healing/remodeling- associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing
2021-09-03
JAMA Network Open
Publication
Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers
2019-05-28
Frontiers in Pharmacology
Publication
Extract From Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1β Through Inhibition of NF-κB Nuclear Translocation and NLRP3 Inflammasome Activation
2012-05-30
Evid Based Complement Alternat Med
Publication
Plectranthus Amboinicus and Centella Asiatica Cream for the Treatment of Diabetic Foot Ulcers
  • ‹
  • 1
  • 2
  • ›
Home
icon Address:35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City, Taiwan (R.O.C.)
icon Phone:+886 (0)2-2703-1098
icon Fax:+886 (0)2-2703-1200
icon Facebook
icon Contact Us
icon Linkedln
Privacy Policy Copyright © Oneness Biotech Co., Ltd.. All Rights Reserved.